Alzheimer's and aducanumab: Unjust profits and false hopes
New in the Hastings Center Report
2021-06-28
(Press-News.org) The U.S. Food and Drug Administration's controversial decision to approve aducanumab for the treatment of Alzheimer's disease raises at least three major ethical issues that need to be addressed, states a new article in the Hastings Center Report:
Billions of dollars in Medicare resources (which is to say, taxpayer dollars) are at risk of being unjustly squandered.
Physicians must choose between facilitating this unjust squandering and denying desperate patients and families access to this drug.
Patients and families are having false hopes legitimated and encouraged when physicians prescribe aducanumab.
The drug's approval was contrary to the nearly unanimous judgment of an FDA advisory committee that there was little reliable evidence of significant benefit. And given the drug's $56,000 annual price and the 3.1 million people who are candidates for the drug, the total cost to Medicare or a private insurer would be $174 billion per year. An additional $93 billion in health care costs would be needed to cover infusion costs and the brain scans needed to monitor the risk of drug side effects, which include brain swelling or small-vessel brain bleeds.
"If the drug reversed and cured Alzheimer's, it would make ethical and economic sense to fully fund access to it, in my view," writes Leonard Fleck, a professor in the Center for Bioethics and Social Justice at Michigan State University. "But it does not do that."
Fleck concludes with a proposal to minimize the ethical issues cited above and set an important precedent for similar drugs in the pipeline. Medicare should require Biogen, the manufacturer, to provide aducanumab at cost--between $2,500 and $5,000 per year--(plus a modest profit) while it conducts further research to establish whether the drug is safe and effective.
Fleck suggests that "this is the best nonideal resolution we can achieve, given competing pressures form intense patient demands and the need for the just and prudent allocation of limited health care resources."
He adds, "Other pharmaceutical companies could expect the same crimped profits . . . if they could not prove decisively that their drug yielded substantial clinical benefits at a reasonable cost. This would be unforgettable tough love."
INFORMATION:
For more information or to receive the full text of the article, contact
Susan Gilbert
Director of Communications
The Hastings Center
gilberts@thehastingscenter.org
845-424-4040 x244
ELSE PRESS RELEASES FROM THIS DATE:
2021-06-28
HOUSTON - (June 28, 2021) - Rice University computer scientists are sending RAMBO to rescue genomic researchers who sometimes wait days or weeks for search results from enormous DNA databases.
DNA sequencing is so popular, genomic datasets are doubling in size every two years, and the tools to search the data haven't kept pace. Researchers who compare DNA across genomes or study the evolution of organisms like the virus that causes COVID-19 often wait weeks for software to index large, "metagenomic" databases, which get bigger every month and are now measured in petabytes.
RAMBO, which is short for "repeated and merged bloom filter," is a new method that can cut indexing times for such ...
2021-06-28
Neurons in the hippocampus fire during specific moments in time, according to research recently published in JNeurosci. The cells may contribute to memory by encoding information about the time and order of events.
Episodic memories involve remembering the "what, where, and when" of past experiences. The "where" may be encoded by place cells in the hippocampus, which fire in response to specific locations. Rodents have hippocampal neurons that fire in response to specific moments in time -- the "when" -- but until recently it was not known if the human brain contained them too.
Reddy et al. recorded the electrical activity of neurons in the hippocampus of epilepsy patients undergoing diagnostic invasive monitoring ...
2021-06-28
In cancer therapy, the effectiveness of an approach is determined by its ability to preserve the non-cancerous cells. Simply put, the higher the collateral damage, the greater are the side-effects of a therapy. An ideal situation is where only the cancer cells can be targeted and destroyed. In this regard, photothermal therapy--an approach in which cancer cells infused with gold nanoparticles can be heated up and destroyed using near-infrared (NIR) light that is strongly absorbed by the gold nanoparticles--has emerged as a promising strategy due to its minimally invasive nature.
"Because NIR light is able to penetrate biological tissues, it can illuminate ...
2021-06-28
The Structural Bioinformatics and Network Biology laboratory, led by ICREA Researcher Dr. Patrick Aloy, has completed the bioactivity information for a million molecules using deep machine-learning computational models. It has also disclosed a tool to predict the biological activity of any molecule, even when no experimental data are available.
This new methodology is based on the Chemical Checker, the largest database of bioactivity profiles for pseudo pharmaceuticals to date, developed by the same laboratory and published in 2020. The Chemical Checker collects information from 25 spaces of bioactivity for each molecule. These spaces are linked to the chemical structure of the molecule, the targets with which it interacts or the changes ...
2021-06-28
For the first time, scientists from the German Cancer Consortium (DKTK) partner site in Essen/Düsseldorf have discovered stem cells of the hematopoietic system in glioblastomas, the most aggressive form of brain tumor. These hematopoietic stem cells promote division of the cancer cells and at the same time suppress the immune response against the tumor. This surprising discovery might open up new possibilities for developing more effective immunotherapies against these malignant brain tumors.
The DKTK is a consortium centered around the German Cancer Research Center (DKFZ) in Heidelberg, which has long-term collaborative partnerships with specialist oncological centers at universities across Germany.
Glioblastomas ...
2021-06-28
Metabolic activators were found to reduce recovery time by as many as 3.5 days in patients with mild-to-moderate Covid-19, according to a Swedish-British study published today in Advanced Science.
The researchers also found that treatment with the metabolic activators improved liver health and decreased the levels of inflammation, as shown by inflammatory markers.
Conducted by researchers at Science for Life Laboratory at KTH Royal Institute of Technology in Stockholm, in collaboration with the Sahlgrenska Academy in Gothenburg and King's College, London, the ...
2021-06-28
Want to have a happy relationship? Make sure both partners feel they can decide on issues that are important to them. Objective power measured by income, for example, doesn't seem to play a big role, according to a new study in the "Journal of Social and Personal relationships" by the Martin Luther University Halle-Wittenberg (MLU) and the University of Bamberg. Instead, how lovers perceive power dynamics in their relationship is most important for relationship satisfaction.
Power is about being able to influence people and successfully resist the attempts of others to influence you. "It sounds like a dog-eat-dog world or the world of business. ...
2021-06-28
The examined tissue does not need to be marked for this. The analysis only takes around half an hour. "This is a major step that shows that infrared imaging can be a promising methodology in future diagnostic testing and treatment prediction," says Professor Klaus Gerwert, director of PRODI. The study is published in the American Journal of Pathology on 1 July 2021.
Treatment decision by means of a genetic mutation analysis
Lung tumours are divided into various types, such as small cell lung cancer, adenocarcinoma and squamous cell carcinoma. Many rare tumour types and sub-types also exist. This diversity hampers reliable rapid diagnostic methods in everyday clinical ...
2021-06-28
There are spiders that eat snakes. Observations of snake-eating spiders have been reported around the world. Two researchers from Basel and the US consolidated and analyzed over 300 reports of this unusual predation strategy.
Spiders are primarily insectivores, but they occasionally expand their menu by catching and eating small snakes. Dr. Martin Nyffeler, arachnologist at the University of Basel, and American herpetologist Professor Whitfield Gibbons of the University of Georgia, USA, got to the bottom of this phenomenon in a meta-analysis. Their findings from ...
2021-06-28
Announcing a new article publication for BIO Integration journal. In this article the authors Chunxiong Zheng, Mingqiang Li and Jianxun Ding from Sun Yat-sen University, Guangzhou, China and Changchun Institute of Applied Chemistry, Changchun, China discuss the challenges and opportunities of nanomedicines in clinical translation.
Researchers are rapidly gaining a much deeper understanding of the challenges and opportunities of nanomedicines allowing for improvements in disease treatment and improved patient survival.
Deep exploration of the connections between preclinical and clinical ...
LAST 30 PRESS RELEASES:
[Press-News.org] Alzheimer's and aducanumab: Unjust profits and false hopes
New in the Hastings Center Report
